• Karakters3_uitwisseling

    Uitwisseling | 交流

  • Karakters_1_samenwerking

    Samenwerking | 合作

  • Karakters2_werelden verbinden

    Werelden verbinden | 国际接轨

  • Karakters_4_kennis

    Kennis | 知识

  • Karakters_5_samenwerking

    Samenwerking | 合作

  • Karakters_6_ontwikkeling

    Ontwikkelingen | 发展

Investors are rushing into China's booming healthcare business, helping M&A deal values surpass those of the hot Internet sector, as the country prepares to cater to hundreds of millions of elderly patients. Encouraged by a relaxation of foreign ownership rules last year and a rapidly aging population, private equity firms such as TPG Capital and industry players including Malaysia's IHH Healthcare are investing in Chinese hospitals, pharmaceutical companies and device makers. The prospect of 223 million people aged 65 or older predicted to live in China by 2030 is just too enticing for these companies, despite significant risks such as weak hospital infrastructure, rising valuations and a dearth of doctors. The companies have begun leveraging connections of local partners to hire doctors, and to help expedite local licenses and permits to start work on planned projects. China has forecast healthcare spending by the private sector, state-owned enterprises and consumers to treble to 8 trillion yuan ($1.3 trillion) over the next five years, as it tries to cope with the boom in its aging population, a result of the country's decades-long one-child policy and current low fertility rate.

"I spend 70 percent of my time looking for healthcare deals . . . . . read more

Zoeken

jan booij
hoogeveen logo
meetin